News

Read the latest news about issues affecting the neuromuscular disease community.

Blog Post

Eledon Announces Positive Topline Results from a Phase 2a Study of Tegoprubart to Treat ALS

By Sujatha Gurunathan | June 1, 2022
Featured Article

MDA’s Care Center Network Expands

By MDA Staff | May 13, 2022
RADICAVA ORS
Blog Post

FDA Approves MTPA’s RADICAVA ORS for Treatment of ALS

By Sujatha Gurunathan | May 13, 2022
Scientific conference speakers
Featured Article

A Successful In-Person Conference

By MDA Staff | May 13, 2022
Blog Post

MDA Tribute Tour Takes Nashville: A Night at the Grand Ole Opry

By MDA Staff | May 3, 2022

FDA Approves Alexion’s Ultomiris for Treatment of gMG

By Sujatha Gurunathan | April 28, 2022
war in ukraine
Blog Post

Living Through War in Ukraine with a Neuromuscular Disease

By Larry Luxner | March 22, 2022
Featured Article

A New Direction for Charcot-Marie-Tooth Disease

By MDA Staff | February 16, 2022
Blog Post

Welcoming the 2022 MDA National Ambassadors

By Mindy Henderson | January 30, 2022
Blog Post

MDA’s 2022 Advocacy Agenda

By Mark Fisher | January 27, 2022